Sign in
4

Changes in Ownership

Monopar Therapeutics Filed Acc 0001437749-24-010722

Chief Financial Officer gave up 4,082 shares (to pay taxes)

  • Chief Financial Officer acquired 9,956 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Tsuchimoto Kim R Chief Financial Officer 2024-03-31 Option exercise +9,956 54,552 D
Tsuchimoto Kim R Chief Financial Officer 2024-03-31 Shares withheld for taxes −4,082 $0.68 $2,780 50,470 D
Derivatives
Tsuchimoto Kim R Chief Financial Officer 2024-03-31 Option exercise · Restricted Stock Units −9,956 84,369 D
Loading xslF345X05/rdgdoc.xml…